Pharmacokinetics and safety of a new bioengineered thrombolytic agent, human tissue urokinase type plasminogen activator in Chinese healthy volunteers. [electronic resource]
Producer: 20110414Description: 97-102 p. digitalISSN:- 0378-7966
- Adult
- Area Under Curve
- China
- Dose-Response Relationship, Drug
- Enzyme-Linked Immunosorbent Assay
- Female
- Fibrinolytic Agents -- administration & dosage
- Half-Life
- Humans
- Injections, Intravenous
- Male
- Protein Engineering -- methods
- Sex Factors
- Software
- Urokinase-Type Plasminogen Activator -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.